Cocrystal Pharma (COCP) 10% Owner Phillip Frost Buys 10,000 Shares

What Happened
Phillip Frost (reported as a 10% owner) bought 10,000 shares of Cocrystal Pharma, Inc. (COCP) in open-market purchases on August 5, 2026. The reported weighted-average price was $0.98 per share, for a total reported value of $9,816. This was a purchase (a bullish signal in the sense of acquisition, though not necessarily indicative of broader intent).

Key Details

• Transaction date: 2026-08-05; Form 4 filed: 2026-08-06 (filed the next day; not marked late).
• Transaction type/code: P (purchase) — open market / private purchase.
• Shares acquired: 10,000 at a weighted-average price of $0.98 (range of individual prices: $0.972–$0.9898 per F1).
• Total reported amount: $9,816.
• Shares owned after transaction: Not specified in the provided excerpt.
• Notable footnotes:
  • F1: Price is a weighted average over multiple trades; reporting person will provide per-trade prices on request.
  • F2: Shares are held by Frost Gamma Investments Trust (structure described); Dr. Frost disclaims beneficial ownership except to the extent of any pecuniary interest.
  • F3: Reported holdings may include shares issuable upon vesting of restricted stock units.
• Remarks clarify this filing excludes securities owned directly by OPKO Health, Inc., and Dr. Frost disclaims beneficial ownership of those shares except for any pecuniary interest.

Context
This is a small open-market purchase by a reported 10% owner via trust structures (not necessarily a direct personal buy). Such purchases are factual signals of accumulation but, given the trust ownership and the modest dollar amount (~$9.8k), investors should treat this as limited in scale and interpret it alongside other insider activity and company fundamentals.